Revenue Summary of PetMed Express, Inc.

PetMed Express, Inc.'s latest annual revenue in 2024 was 281.06 Million USD , up 9.42% from previous year.
PetMed Express, Inc.'s latest quarterly revenue in 2024 FY was 281.06 Million USD , up 9.42% from previous quarter.
PetMed Express, Inc. reported a annual revenue of 256.85 Million USD in annual revenue 2023, down -6.06% from previous year.
PetMed Express, Inc. reported a annual revenue of 273.41 Million USD in annual revenue 2022, down -11.58% from previous year.
PetMed Express, Inc. reported a quarterly revenue of 65.31 Million USD for 2024 Q3, down -8.0% from previous quarter.
PetMed Express, Inc. reported a quarterly revenue of 78.24 Million USD for 2024 Q1, up 25.38% from previous quarter.

Annual Revenue Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Revenue of PetMed Express, Inc. (2024 - 2000)

Year	Revenue	Revenue Growth
2024	281.06 Million USD	9.42%
2023	256.85 Million USD	-6.06%
2022	273.41 Million USD	-11.58%
2021	309.21 Million USD	8.83%
2020	284.12 Million USD	0.25%
2019	283.41 Million USD	3.51%
2018	273.8 Million USD	9.88%
2017	249.17 Million USD	6.18%
2016	234.68 Million USD	2.31%
2015	229.39 Million USD	-1.71%
2014	233.39 Million USD	2.44%
2013	227.82 Million USD	-4.37%
2012	238.25 Million USD	2.85%
2011	231.64 Million USD	-2.78%
2010	238.26 Million USD	8.59%
2009	219.41 Million USD	16.5%
2008	188.33 Million USD	16.08%
2007	162.24 Million USD	17.93%
2006	137.58 Million USD	26.97%
2005	108.35 Million USD	15.28%
2004	93.99 Million USD	70.98%
2003	54.97 Million USD	71.66%
2002	32.02 Million USD	220.06%
2001	10 Million USD	-31.82%
2000	14.67 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q4	66.5 Million USD	1.82%
2024 Q3	65.31 Million USD	-8.0%
2024 Q1	78.24 Million USD	25.38%
2024 Q2	70.99 Million USD	-9.26%
2024 FY	281.06 Million USD	9.42%
2023 Q1	70.18 Million USD	6.34%
2023 FY	256.85 Million USD	-6.06%
2023 Q2	65.39 Million USD	-6.83%
2023 Q3	58.87 Million USD	-9.98%
2023 Q4	62.4 Million USD	6.01%
2022 Q1	79.31 Million USD	10.65%
2022 FY	273.41 Million USD	-11.58%
2022 Q2	67.38 Million USD	-15.04%
2022 Q4	66 Million USD	8.7%
2022 Q3	60.71 Million USD	-9.9%
2021 Q2	75.43 Million USD	-21.59%
2021 FY	309.21 Million USD	8.83%
2021 Q3	65.89 Million USD	-12.65%
2021 Q4	71.67 Million USD	8.78%
2021 Q1	96.2 Million USD	29.5%
2020 Q4	74.28 Million USD	23.99%
2020 Q3	59.91 Million USD	-14.33%
2020 Q1	79.98 Million USD	23.89%
2020 Q2	69.93 Million USD	-12.57%
2020 FY	284.12 Million USD	0.25%
2019 Q2	71.39 Million USD	-18.3%
2019 Q1	87.39 Million USD	29.81%
2019 FY	283.41 Million USD	3.51%
2019 Q4	64.56 Million USD	7.49%
2019 Q3	60.06 Million USD	-15.87%
2018 Q2	66.71 Million USD	-16.25%
2018 Q1	79.65 Million USD	26.38%
2018 Q4	67.32 Million USD	12.0%
2018 FY	273.8 Million USD	9.88%
2018 Q3	60.11 Million USD	-9.89%
2017 Q4	63.03 Million USD	19.23%
2017 Q2	60.79 Million USD	-16.14%
2017 Q1	72.48 Million USD	30.86%
2017 FY	249.17 Million USD	6.18%
2017 Q3	52.86 Million USD	-13.04%
2016 Q4	55.39 Million USD	8.75%
2016 FY	234.68 Million USD	2.31%
2016 Q3	50.93 Million USD	-10.21%
2016 Q2	56.72 Million USD	-20.81%
2016 Q1	71.63 Million USD	43.29%
2015 Q1	72.54 Million USD	49.16%
2015 Q2	57.57 Million USD	-20.63%
2015 Q3	49.28 Million USD	-14.4%
2015 Q4	49.99 Million USD	1.44%
2015 FY	229.39 Million USD	-1.71%
2014 FY	233.39 Million USD	2.44%
2014 Q2	60.47 Million USD	-18.49%
2014 Q3	50.08 Million USD	-17.18%
2014 Q4	48.63 Million USD	-2.9%
2014 Q1	74.19 Million USD	45.14%
2013 FY	227.82 Million USD	-4.37%
2013 Q4	51.12 Million USD	3.05%
2013 Q3	49.6 Million USD	-14.68%
2013 Q2	58.14 Million USD	-15.68%
2013 Q1	68.95 Million USD	23.3%
2012 Q4	55.92 Million USD	10.69%
2012 Q2	58.22 Million USD	-20.87%
2012 FY	238.25 Million USD	2.85%
2012 Q3	50.52 Million USD	-13.23%
2012 Q1	73.57 Million USD	44.53%
2011 Q4	50.91 Million USD	12.84%
2011 FY	231.64 Million USD	-2.78%
2011 Q3	45.11 Million USD	-26.33%
2011 Q1	74.36 Million USD	47.86%
2011 Q2	61.24 Million USD	-17.65%
2010 Q1	77.16 Million USD	60.53%
2010 Q2	62.44 Million USD	-19.08%
2010 FY	238.26 Million USD	8.59%
2010 Q3	48.35 Million USD	-22.57%
2010 Q4	50.29 Million USD	4.02%
2009 Q1	68.36 Million USD	69.13%
2009 Q2	59.56 Million USD	-12.87%
2009 Q4	48.07 Million USD	10.75%
2009 FY	219.41 Million USD	16.5%
2009 Q3	43.4 Million USD	-27.13%
2008 Q4	40.42 Million USD	8.23%
2008 FY	188.33 Million USD	16.08%
2008 Q3	37.34 Million USD	-27.53%
2008 Q2	51.53 Million USD	-12.69%
2008 Q1	59.02 Million USD	62.13%
2007 FY	162.24 Million USD	17.93%
2007 Q4	36.4 Million USD	16.13%
2007 Q3	31.35 Million USD	-28.44%
2007 Q2	43.81 Million USD	-13.54%
2007 Q1	50.67 Million USD	72.31%
2006 Q4	29.4 Million USD	13.59%
2006 Q3	25.89 Million USD	-33.02%
2006 Q2	38.65 Million USD	-11.41%
2006 Q1	43.63 Million USD	85.42%
2006 FY	137.58 Million USD	26.97%
2005 Q2	28.75 Million USD	-18.52%
2005 Q1	35.28 Million USD	64.38%
2005 Q3	20.78 Million USD	-27.72%
2005 Q4	23.53 Million USD	13.23%
2005 FY	108.35 Million USD	15.28%
2004 Q2	24.96 Million USD	-17.83%
2004 FY	93.99 Million USD	70.98%
2004 Q3	17.16 Million USD	-31.24%
2004 Q1	30.38 Million USD	104.43%
2004 Q4	21.46 Million USD	25.03%
2003 FY	54.97 Million USD	71.66%
2003 Q1	14.83 Million USD	39.25%
2003 Q4	14.86 Million USD	34.52%
2003 Q2	14.22 Million USD	-4.05%
2003 Q3	11.05 Million USD	-22.34%
2002 Q1	5.36 Million USD	84.52%
2002 Q4	10.65 Million USD	29.11%
2002 Q3	8.24 Million USD	6.26%
2002 Q2	7.76 Million USD	44.73%
2002 FY	32.02 Million USD	220.06%
2001 Q2	2.66 Million USD	1.16%
2001 FY	10 Million USD	-31.82%
2001 Q1	2.63 Million USD	-14.39%
2001 Q3	1.79 Million USD	-32.69%
2001 Q4	2.9 Million USD	61.9%
2000 FY	14.67 Million USD	0.0%
2000 Q4	3.08 Million USD	0.0%

Peer Revenue Comparison of PetMed Express, Inc.

Name	Revenue	Revenue Difference
CannBioRx Life Sciences Corp.	- USD	-Infinity%
BIMI International Medical Inc.	11.83 Million USD	-2275.782%
China Jo-Jo Drugstores, Inc.	154.54 Million USD	-81.87%
Harrow Health, Inc. 8.625% Senior Notes due 2026	130.19 Million USD	-115.883%
Harrow Health, Inc. 11.875% Senior Notes due 2027	130.19 Million USD	-115.883%
Leafly Holdings, Inc.	42.25 Million USD	-565.209%
Leafly Holdings, Inc.	42.25 Million USD	-565.209%
LifeMD, Inc.	152.54 Million USD	-84.247%
LifeMD, Inc.	152.54 Million USD	-84.247%
TRxADE HEALTH, Inc.	8.27 Million USD	-3297.688%
Walgreens Boots Alliance, Inc.	147.65 Billion USD	99.81%

Global Stocks Search

PetMed Express, Inc. (PETS)

Revenue Summary of PetMed Express, Inc.

Annual Revenue Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Revenue of PetMed Express, Inc. (2024 - 2000)

Peer Revenue Comparison of PetMed Express, Inc.